Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis.
Mentzel TQ , van der Snoek R , Lieverse R , Oorschot M , Viechtbauer W , Bloemen O , van Harten PN 
J Clin Psychiatry.2018 Sep 18 ; 79(6):.
PubMedで表示
Google翻訳で開く
(23view , 0users)
Full Text Sources
Tardive dyskinesia (TD) is an antipsychotic-induced movement disorder that typically occurs after long-term exposure to antipsychotic drugs. There is evidence that switching to clozapine reduces TD. This meta-analysis reviews the effect of switching to clozapine on the severity of TD.
PMID: 30257080 [PubMed - in process]
PMID: 30257080 [PubMed - in process]
関連論文
- Clozapine efficacy in tardive dyskinesia in schizophrenic patients.
- Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
- Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
- Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.